STOCKHOLM, Nov. 3, 2021 /PRNewswire/ -- The board of
directors for Medicover AB (publ) has today resolved to issue
1,200,000 new class C shares and to immediately thereafter
repurchase such 1,200,000 issued class C shares, for the purpose of
the long term performance-based share programs for key individuals
as approved by the annual general meetings held on 3 May 2019, 30 April
2020 and 29 April 2021 (the
"Plan 2019", the "Plan 2020" and the "Plan 2021").
Today's resolution by the board of directors was passed based on
the authorisation granted by the annual general meeting held on
29 April 2021.
Nordea Bank Abp will subscribe for all issued class C shares at
a subscription price of EUR 0.2 per share. All such 1,200,000
issued class C shares will be repurchased by Medicover AB (publ) at
a purchase price of EUR 0.2 per
share. Following the share issue, the share capital will increase
by EUR 240,000. The class C shares do
not entitle to dividends and each share entitles to 1/10 voting
right.
The purpose of the share issue and the repurchase is to enable
future delivery of performance shares in accordance with the
incentive programs the Plan 2019, the Plan 2020 and the Plan 2021
as well as to cover any social charges associated with the
programs. The class C shares will be converted to class B shares
before delivery to the participants in the programs.
Medicover AB (publ) currently holds 2,384,644 class C shares and
will, following the repurchase of the new 1,200,000 issued class C
shares, hold all 3,584,644 class C shares in the company.
For further information, please contact:
Hanna Bjellquist, Head of
Investor Relations
+46 703 033 272
hanna.bjellquist@medicover.com
Medicover is required to publish the information contained in
this press release pursuant to the Swedish Financial Instruments
Trading Act. The information was provided for publication by the
abovementioned contact person at 08.30 CET on 3 November 2021.
Medicover is a leading international healthcare and diagnostic
services company and was founded in 1995. Medicover operates a
large number of ambulatory clinics, hospitals, specialty-care
facilities,laboratories and blood-drawing points and the
largest markets are Poland and
Germany. In 2020, Medicover had
revenue of EUR 998 million and more
than 32,000 employees. For more information, go to
www.medicover.com
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/medicover/r/issue-and-repurchase-of-class-c-shares-for-incentive-program,c3445788
The following files are available for download:
|
https://mb.cision.com/Main/15662/3445788/1490457.pdf
|
Issue and repurchase
of Class C shares for incentive program
|
